S&P 500 down 2%; Mobilicom Stock Soars Higher – Aileron Therapeutics…

S&P 500 down 2%; Mobilicom Stock Soars Higher – Aileron Therapeutics…

Facebook
Twitter
LinkedIn

US stocks traded lower towards the end of trade, with the Nasdaq Composite falling more than 2% on Tuesday.

The Dow fell 2.06% to 33,129.04, while the NASDAQ fell 2.39% to 11,506.10. The S&P 500 was also down 2.05% to 3,995.66.

Look at that: $3 million bet on this biotech stock? Check out these 3 penny stocks that insiders are buying

Leading and lagging sectors

  • Energy stocks rose around 0.1% on Tuesday. Meanwhile top winner in the sector included Helix Energy Solutions Group, Inc. HLXup to 15% and StealthGas Inc. GASincreased by 5%.
  • In Tuesday’s trading, consumer discretionary stocks fell 2.8%.

top heading

The S&P Global Manufacturing PMI for the US rose to 47.8 in February from 46.9 in the previous month, while the composite PMI rose to 50.2 in February from 46.8 in the previous month.

Stock trading UP

  • Harbor Custom Development, Inc. HCDI Shares soared 57% to $0.55 after the company announced it had agreed to sell townhomes in Mills Crossing for $14.25 million.
  • shares of Arbe Robotics Ltd. WORK got a boost and rose 49% to $6.50. Arbe Robotics is expected to report its fourth quarter financial results on Thursday, March 2, 2023.
  • Mobilicom Limited MOB Shares also rose, gaining 43% to $2.21 after the company announced it had entered into a strategic partnership with Mistral, a prime contractor for the US Department of Defense.

Stocks are trading down

  • Aileron Therapeutics, Inc. ALRN Shares fell 45% to $1.30 after the company announced the completion of the Phase 1b breast cancer chemoprotection trial and the exploration of strategic alternatives.
  • shares of CVRx, Inc. CVRX fell 50% to $8.52 after the company announced preliminary results from the BeAT-HF post-marketing randomized clinical trial.
  • EFFECTOR Therapeutics, Inc. EFTR declined, falling 20% ​​to $0.5055 after the company announced top-line results from its phase 1b clinical trial of zotatifin for COVID-19 infection.

Also check out: Ethereum falls but stays above $1,600;…

[ad_2]

Source story

More to explorer